tiprankstipranks
Advertisement
Advertisement
Orchestra granted additional breakthrough device designation for AVIM therapy
PremiumThe FlyOrchestra granted additional breakthrough device designation for AVIM therapy
1M ago
Orchestra BioMed: Accelerating Pivotal Trials and Strengthened Liquidity Support Buy Rating and Long‑Term Growth Outlook
Premium
Ratings
Orchestra BioMed: Accelerating Pivotal Trials and Strengthened Liquidity Support Buy Rating and Long‑Term Growth Outlook
3M ago
Midday Fly By: Dick’s Sporting, Dollar General report quarterly beats
Premium
The Fly
Midday Fly By: Dick’s Sporting, Dollar General report quarterly beats
3M ago
Orchestra BioMed Adopts 2026 Performance-Driven Executive Compensation Plan
PremiumCompany AnnouncementsOrchestra BioMed Adopts 2026 Performance-Driven Executive Compensation Plan
4M ago
Orchestra BioMed gains cash from Vivasure sale proceeds
Premium
Company Announcements
Orchestra BioMed gains cash from Vivasure sale proceeds
5M ago
Orchestra BioMed to receive up to $21M in proceeds from Vivasure acquisition
Premium
The Fly
Orchestra BioMed to receive up to $21M in proceeds from Vivasure acquisition
5M ago
Orchestra BioMed price target lowered to $11 from $12 at Barclays
PremiumThe FlyOrchestra BioMed price target lowered to $11 from $12 at Barclays
7M ago
Orchestra BioMed reports Q3 EPS (40c), consensus (43c)
Premium
The Fly
Orchestra BioMed reports Q3 EPS (40c), consensus (43c)
7M ago
Orchestra BioMed files to sell 8.03M shares of common stock for holders
Premium
The Fly
Orchestra BioMed files to sell 8.03M shares of common stock for holders
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100